- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02612402
Effect of Smartphone App on Activity
The Effect of a Smartphone Application for Encouraging Physical Activity on the Amount of Activity Performed by Patients With Diabetes or Hematological Malignancies
Study Overview
Status
Conditions
Detailed Description
The aim of the study is to increase patients' physical activities by using a dedicated cellular application that will encourage patients to adhere to their doctor recommendation on a personal basis.
Primary outcome In diabetic patients: measuring an increase in daily physical activity In cancer patients: improvement of quality of life in correlation with the level of physical activity
Secondary outcomes In diabetic patients: improved glycemic control as assessed by sequential blood tests for HbA1c.
The patients will fill quality of life questionnaires (SF36) at recruitment and after 6 months. After 6 months the patients will also fill a questionnaire about their experience of using the app.
Each recruited patient will have an Android based smart phone. Each patient will provide:
- Approval to join the experiment
- Age, gender, height
- Telephone number (for SMS)
Length of intervention - at least 6 months per patient. Each patient will be randomly assigned into one of two groups, which will specify feedback relative to himself or to others or a weekly reminder to exercise.
Number of patients:
- Diabetes: 150 patients, of which 50 are controls.
- Cancer: 100 patients, of which 20 are controls. All patients will receive instruction about the importance of physical activity and a personal recommendation for activity level, n sessions of activity per week, and time span per session (i.e., at least 2 hours of walking per week divided to 3 walking sessions per week) Patients in the treatment arms will receive at least n (number of commended sessions) messages per week of positive feedback if activity performed or negative feedback if not performed. At the chosen day each week the patient will receive a summary of the exercise for all the week.
Feedback Possible feedback
(NOTE - these the the actual feedback messages that the participants will receive, and are therefore in the second person):
- Negative feedback: "You need to exercise to reach your activity goals. Please remember to exercise tomorrow".
Positive feedback:
- Relative to self: "You're exercise level is higher than last week. Keep up the good work"
- Relative to others: "You're exercising more than the average person. Keep up the good work"
- Control arm: "Did you remember to exercise?"
Technical requirements
- App - will collect physical activity and send it to a server. App will run in background without need to restart on reboot.
- Server - Collects physical activity
Feedback policies The experiment will have two phases of feedback. Phase 1
The investigators begin with no data, so the policy at this stage is as follows:
- Positive feedback will be sent each day if user has surpassed 1/7th of weekly activity that day.
- Negative feedback will be sent every 3 days, if activity hasn't passed 1/7th of activity.
Each day, with a probability of 0.2, a random decision on feedback will be made.
This phase will last approximately 4 weeks. Phase 2 Using a learning algorithm (see below) the computer will adjust the feedback, and decide daily on the feedback (positive \ negative \ none).
Policy learning The investigators will start with a simple policy learning strategy, and later use more sophisticated methods that will have a state-space representation of the user.
The initial algorithm will represent each user at each day using the following attributes:
- Demographics (age and gender)
- Expected versus actual activity level this week (ratio of the two)
- Last feedback given (positive \ negative)
- Day of the week (we will use week-long cycles). The goal of the algorithm is to give feedback today so as to encourage activity tomorrow.
When training the algorithm, the computer will have a feature vector comprising of the attributes above, and a matrix of actions (for day t). The output to be predicted is whether the activity level on the following day (t+1).
There can be two types of feedback depending on weekly and daily behaviors:
Weekly goal Not achieved Achieved Daily goal (on day (t+1)) Not achieved 1 1+alpha Achieved 1+alpha 1 (alpha>0) The algorithm will pay a higher penalty if, for example, on a given day the message encouraged activity, but the weekly goal was not achieved compared to if it was.
For simplicity, the initial learning algorithm will be linear, until enough data is collected. That is, given a matrix:
X = (demographics, expected vs. actual activity, last feedback, day of the week, actions) And a vector showing the amount of activity on the following day, weighted as in the table above, denoted by Y, we will learn a vector of weights w such that: X * w = Y.
In phase 2 of the project the computer will use other learning algorithms. Exploration (random action at a given day) will continue throughout both phases at the same level.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Irit a Hochberg, MD/PhD
- Phone Number: +97247772150
- Email: i_hochberg@rambam.health.gov.il
Study Locations
-
-
-
Haifa, Israel
- Recruiting
- Rambam Health Care Campus
-
Contact:
- Irit Hochberg, MD/PhD
- Phone Number: +972-4-7772150
- Email: i_hochberg@rambam.health.gov.il
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age over 18.
- Diagnosis of diabetes type 2 with HbA1c over 6.5% and no regular exercise for arm A.
- Newly diagnosed lymphoma, CLL or MM which require chemotherapy for arm B.
- Patients in both arms should hold an android based smartphone.
- Patients must be able to read Hebrew.
Exclusion Criteria:
- Unable to legally consent
- unstable or stable angina pectoris
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Learning algorithm
The app will be installed on the patients's phone.
The app will measure the amount of activity performed.
THE INTERVENTION IS THAT the Patients will receive daily messages, a learning algorithm will study the exercise response to each type of message and personalize the best message sequence for each patient.
|
THIS INTERVENTION HAS BEEN INCLUDED IN THE LEARNING ALGORITHM ARM The app measures physical activity by the phone accelerometer and sends SMS messages to encourage activity.
An automatic learning algorithm for encouraging physical activity learns the patterns of response for each patient and chooses the best messages for the patient to encourage activity.
|
Active Comparator: control
The app will be installed on the patients's phone.
The app will measure the amount of activity performed.
THE INTERVENTION IS THAT THE Patients will receive a weekly reminder to exercise.
|
THIS INTERVENTION HAS BEEN INCLUDED IN THE CONTROL ARM The app measures physical activity by the phone accelerometer and sends a constant SMS messages to remind the patient to exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
increase in daily physical activity
Time Frame: 6 months
|
The app records the amount of daily walking using the smartphone accelerometer.
The amount of activity and pace of walking is compared to those performed on previous days.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
glycemic control
Time Frame: 6 months
|
HbA1c will be measured before recruitment and every 3 months during participation.
The HbA1c during participation will be compared to the starting HbA1c to assess whether there was improvement in glycemic control as quantified by HbA1c.
|
6 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0090-14-RMB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hematologic Malignancy
-
St. Jude Children's Research HospitalRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Scripps Translational Science InstituteCompleted
-
Millennium Pharmaceuticals, Inc.Completed
-
Guardant Health, Inc.CompletedNon-Hematologic MalignancyUnited States
-
CCTU- Cancer ThemeRecruitingCancer | Non-Hematologic MalignancyUnited Kingdom
-
Century Therapeutics, Inc.RecruitingHematological Malignancy | Solid Tumor MalignancyUnited States
-
Princess Maxima Center for Pediatric OncologyRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyNetherlands
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingHematologic MalignancyChina
Clinical Trials on messages generated by learning algorithm
-
Duke UniversityUniversity of California, San FranciscoCompletedChemotherapeutic ToxicityUnited States
-
ChronolifeUnknown
-
Norwegian University of Science and TechnologyHelse Nord-Trøndelag HF; SINTEF Health ResearchRecruitingLung Cancer | Artificial Intelligence | Endobronchial UltrasoundNorway
-
Chang Gung Memorial HospitalCompletedMachine Learning | Spleen InjuryTaiwan
-
Duke UniversityCompletedChemotherapeutic Toxicity | Radiation Therapy ComplicationUnited States
-
London North West Healthcare NHS TrustImperial College LondonActive, not recruiting
-
National Taiwan University HospitalTaiwan Emergency Medical Technician AssociationNot yet recruiting
-
Mayo ClinicDayTwoCompletedHealthy VolunteersUnited States
-
CRG UZ BrusselUnknownDiabetic Retinopathy | Cataract | Central Serous Chorioretinopathy